logo
  

Cisco Deploys Tableau Across Multiple Business Divisions In EMEA

Tableau Software (DATA) Wednesday said Cisco has deployed Tableau across multiple business divisions in EMEA, in order to drive efficiency and better inform every part of the business, from senior business planning to in-field sales.

According to Tableu, Cisco's business intelligence team recognised that the company needed to better connect the dots and provide useful insight into business data that everyone could use.

In order to more easily understand their data, a group of five people from within the business chose Tableau to gain deeper insights.

Recognising the potential for this data visualisation tool, and with the vision of making data available and understandable to everyone, the EMEA Business Insights team secured senior buy-in to expand the solution and began to implement it more widely.

Proving to be very popular, within six months the number of active community members has grown from 5 to more than 40, supporting an audience of over 1500 active data consumers.

Specific areas that were in need of greater insight into business data were the sales and channel organizations. Having established Tableau as a vital source of easily-understood business insight, the Business Insights team launched a mobile BI platform, accessed via mobile devices.

After equipping the majority of the in-field sales team with tablets, these representatives are now able to access sales data - and more - straight away, all through a user-friendly interface, enabling quicker sales.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT